News | 2022.07.11
Following the release of the 2021 edition of the Institut Pasteur's Annual Report, here are some of the year's highlights. Twelve eventful months interspersed with highlightsmajor scientific breakthroughs and key events for the institute in all fields including COVID-19, cancer, neuroscience, genetics, vaccinology and antibiotic resistance.
News | 2017.11.27
Although there is an effective vaccine, rabies is still present in over 150 countries worldwide. The countries of the Middle East and Central Asia are particularly affected by this viral disease, including Iran where rabies is endemic.In order to strengthen the surveillance and control of rabies in these regions, the Institut Pasteur in Iran organized an international workshop, from October 8 to...
News | 2018.03.09
The Palais de la découverte is offering a lecture cycle to coincide with the "Pasteur, the Experimenter" exhibition, with scientific advice from Maxime Schwartz, former President of the Institut Pasteur and scientific curator of the exhibition. Note that the exhibition will be held at the Palais de la découverte until August 19, 2018.Louis Pasteur, a qualified chemist, was behind the greatest...
News | 2018.06.18
In official relation with WHO since 2016, the Pasteur International Network Association, represented by Nadia Khelef, presented 3 statements during the 71st World Health Assembly held in Geneva from 21 to 26 May 2018.The first statement supported the program to combat the global shortage of effective and affordable quality medicines and vaccines and to promote access to them. In particular, the...
News | 2023.06.16
Five major themes were at the core of 2022 research advances: emerging infectious diseases, antimicrobial resistance, brain connectivity and neurodegenerative diseases, cancer, vaccinology and immunotherapy. They have honored Institut Pasteur's 2019-2023 strategic plan.
Document de presse | 2014.06.09
Scientists from the Institut Pasteur in Paris, the Institut Pasteur of Shanghai and INSERM research unit 1041, "Immune Regulation and Vaccinology", in collaboration with the Paris Public Hospital Network, have recently demonstrated the existence of immunological memory cells in fetuses. These cells are developed in utero and are capable of producing an inflammatory-type immune response...
Document de presse | 2007.03.11
The various BCG strains used to vaccinate against tuberculosis throughout the world may not all have the same level of effectiveness. This was the conclusion of a study conducted by researchers from Institut Pasteur, published today in the "Proceedings of the National Academy of Science, USA". Press release Paris, march 12, 2007 Over three billion individuals...
Document de presse | 2004.02.19
Two teams from the Institut Pasteur and Inserm, in co-operation with Malaysian researchers, have recently successfully tested a candidate vaccine against the Nipah Virus. This virus, still undiscovered in 1998, was responsible for the deaths of 105 people in Malaysia in 1999. It is expanding at an alarming speed in South-East Asia. Currently there is no treatment in the fight against this...
News | 2020.09.03
Monkeypox is an emerging infectious disease for which outbreak frequency and expected outbreak size in human populations have steadily increased. The geographic spread of monkeypox cases has expanded beyond the forests of central Africa, where cases were initially found, to other parts of the world, where cases have been imported. This transmission pattern is likely due to the worldwide decline...
Article | 2024.04.30
From Nice to Lille, via Ho Chi Minh City and Phnom Penh, many schools, hospitals and streets are named after Calmette. And for good reason, as all of these were places where Albert Calmette worked to improve hygiene and healthcare. A pioneer of social medicine, his work on tuberculosis focused on both research and health education.